drugset / Trial / NCT00302523
Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is: * To explore the potential role of tacrolimus in the treatment of membranous nephropathy. * To investigate the safety and tolerability of tacrolimus vs methylprednisolone plus cyclophosphamide.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | 0.1 mg/kg | Oral |